C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
It includes multiple studies demonstrating that post-translational modifications of conformational variants of p53 are associated with the pathogenesis of Alzheimer's Disease
Mahajan Imaging, which currently has 10 high-end medical diagnostic centres in Delhi-NCR and Jaipur, has ventured into a new field called Integrated Diagnostics
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
A major unresolved question in the field, however, is how do this machinery rapidly searches for and finds rare stretches of damage amid the "vast fields" of undamaged DNA
A staggering 65% of the TB cases in India are in the 15-45 age group
The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
Subscribe To Our Newsletter & Stay Updated
